1. , . Pediatric pacemakers and ICDs: how to optimize perioperative care. Paediatr Anaesth 2011; 21(5); 512–21.
2. , , et al. Patient, procedural and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm 2004; 1: 150–9.
3. , , et al. Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation 2001; 103: 2585–90.
4. , , . Disasters in pediatric cardiac catheterization laboratory. Ain Shams J Anesthesiol 2012; 5 (2): 121–5.
5. . Pacemakers and deﬁbrillator therapy in pediatrics and congenital heart disease. Future Cardiol 2008; 4: 469–79.
6. . Implantable cardioverter deﬁbrillator-related complications in the pediatric population. Pacing Clin Electrophysiol 2009; 32: S71–S74.
7. , , et al. Optimal maximum tracking rate of dual chamber pacemakers required by children and young adults for a maximal cardiorespiratory performance. Pacing Clin Electrophysiol 2005; 28: 378–83.
8. , , et al. Naspe Position Statement. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. Pacing Clin Electrophysiol 2002; 25: 260–4.
9. , . Current perioperative management of the patient with a cardiac rhythm management device. Semin Cardiothorac Vasc Anesth 2009; 13: 31–43.
10. , , et al. Role of permanent pacing to prevent atrial ﬁbrillation. Circulation 2005; 111: 240–3.
11. , , et al. ACC/AHA/HRS2008 guide- lines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: E350–E408.
12. , . Interventional cardiac catheterization in congenital heart disease. Arch Dis Child 2004; 89 (12): 1168–73.
13. , Marcus R, Stokes M. Incidents and complications during pediatric cardiac catheterization. Paediatr Anaesth 2005; 15(12): 1083–8.
14. et al. Surgical emergencies during pediatric interventional catheterization. J Pediatr 2002 140(5): 570–5.
15. et al. Impact of how body weight on frequency of pediatric cardiac catheterization complications. Am J Cardiol 2000 86(11): 1275–8.
16. , , . Electrocardiography and introduction to electrophysiologic techniques. In , , , eds. Nada’s Pediatric Cardiology, 2nd edition. Philadelphia, PA: Elsevier. 2006. pp.145–72.
17. , , , et al.Out of operating room procedures: pediatric catherizarion and electrophysiology. Anesthesiologist’s Manual of Surgical Procedures, 4th edition. Philadelphia, PA: Lippincott Williams and Wilkins. 2009. Pp. 1493–5.
18. , et al. Pediatric electrocardiography and cardiac electrophysiology. Pediatric Cardiac Anesthesiology 2005; 138–51.
19. , , et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005; 46: 2277–83.
20. , , et al. A multicenter experience with novel implantable cardioverter deﬁbrillator conﬁgurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006; 17: 41–6.
21. . The patient with a cardiac pacemaker or implanted deﬁbrillator and management during anesthesia. Anesthesia and medical disease. Current Opin Anaesthesiol 2007; 20: 261–8.
22. , , et al. Results of a multicenter retrospective implantable cardioverter-deﬁbrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51: 1685–91.
23. , , et al. Sudden cardiac death and the use of implantable cardioverter deﬁbrillators in pediatric patients. Circulation 1993; 87: 800–7.
24. , , et al. Implications of implantable cardioverter deﬁbrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004; 15: 72–6.
25. , , et al. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter deﬁbrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Anesthesiology 2005; 103: 186–98.
26. , . Interaction of an implanted pacemaker with a transesophageal atrial pacemaker: report of a case. J Clin Anesth 1999; 11: 669–71.
27. , . Apparent pacemaker failure caused by activation of ventricular threshold test by a magnetic instrument during general anaesthesia. Br J Anaesth 1992; 69: 645–6.
28. . Pacemaker failure during transurethral resection of the prostate. Anesthesia 1993; 48: 136–8.
29. . Perioperative management of outpatients with implantable cardioverter deﬁbrillators. Curr Opin Anaesthesiol 2009; 22: 701–4.
30. . Review of electrical interference in implanted cardiac devices. Pacing Clin Electrophysiol 2003; 26: 923–5.
31. , . Myocardial stimulation threshold in patients with cardiac pacemakers: effect of physiologic variables, pharmacologic agents, and lead electrodes. Cardiol Clin 1985; 3: 527–37.
32. . Cardiopulmonary bypass in infants and children: what’s new?South African Journal of Anesthesia and Analgesia 2010; 16 (1): 25–7.
33. , . Factors influencing neurologic outcome after neonatal cardiopulmonary bypass: what we can and cannot control. Ann Thoracic Surg 2006; 81: S2381–S2388.
34. , , . Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants. Ann Thoracic Surg 2003; 75: S729–S734.
35. , , . Smith’s Anesthesia for Infants and Children, 8th edition. Elsevier, 2011.
36. , , , . Cardiopulmonary Bypass Principles and Practice, 3rd edition. Lippincott, Williams and Wilkins, 2008.
37. , . Pediatric Cardiac Anesthesia, 4th edition. Lippincott, Williams and Wilkins, 2005.
38. , , , . Effects of miniaturization in reducing inflammatory response to infant cardiopulmonary bypass by elimination of allogeneic blood products. Ann Thorac Surg 2006; 81: S2367–S2372.
39. . Anaesthetic implications of frown-up congenital heart disease. Br J Anaesth 2004; 93(1): 129–39.
40. , , . Anesthesia in adult patients with congenital heart disease. Curr Opin Anaesthesiol 2009; 22: 88–94.
41. , . Challenges posed by adults with repaired congenital heart disease. Circulation 2001: 103: 2637–43.
42. , , . Pathophysiology of congenital heart disease in the adult, Part II: Simple obstructive lesions. Circulation 2008; 117: 1228–37.
43. , , . Pathophysiology of congenital heart disease in the adult, Part I: Shunt lesions. Circulation 2008; 117: 1090–9.
44. , , et al. Management of grown up congenital heart disease. Task force of European Society of Cardiology 2003. Eur Heart J 2003 l; 24: 1035–84.
45. , , et al. Task force: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001; 37: 1170–8.
46. , , et al. Congenital heart disease in the general population; changing prevalence and age distribution. Circulation 2007; 115: 163–2.
47. , . Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?Pediatr Crit Care Med 2010; 11(2 Suppl): S57–S69.
48. , , et al. Response to inhaled nitric oxide predicts survival in patients with pulmonary hypertension. J Card Fail 2011; 17(4): 265–71.
49. . Changing demographics of pulmonary arterial hypertension in congenital heart disease. Eur Respir Rev 2010; 19(118): 308–13.
50. , , et al. Gender differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Chest 2012; 141(2): 363–73.
51. , , , . Sex-related disparity in surgical mortality among pediatric patients. Congenit Heart Dis 2006; 1(3): 77–88.
52. , , et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: executive summary. Circulation 2008; 118: 2395–451.